Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

Raja Mudad, Manish B. Patel, Sandra Margunato-Debay, David Garofalo, Lincy S. Lal

Research output: Contribution to journalArticle

8 Scopus citations

Fingerprint Dive into the research topics of 'Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting'. Together they form a unique fingerprint.

Medicine & Life Sciences